Prime Medicine
2 known investors
Prime Medicine develops Prime Editing, a gene editing platform designed to correct disease-causing mutations in the human genome. The company targets patients with genetic diseases and aims to provide potentially curative treatments through precise DNA replacement at the natural genomic location.